Membranoproliferative glomerulonephritis complicating Waldenström’s macroglobulinemia
© Kratochvil et al.; licensee BioMed Central Ltd. 2012
Received: 11 July 2012
Accepted: 19 December 2012
Published: 21 December 2012
Lymphoproliferative disorders causing paraproteinemia can be associated with various kidney injuries including the deposition of monoclonal immunoglobulins (Ig). A known glomerular manifestation of Waldenström’s macroglobulinemia is characterized by prominent intracapillary hyaline thrombi and lack of conspicuous glomerular proliferation. The present case was special in 2 aspects: 1. the diagnosis of glomerulonephritis was unexpected before renal biopsy, 2. the prominent glomerular proliferation paired with large intracapillary hyaline thrombi is uncommon in Waldenström’s macroglobulinemia-associated glomerulonephritis.
A 73-year-old Caucasian woman with a long-standing history of rheumatoid arthritis and Waldenström’s macroglobulinemia was admitted for acute renal failure (ARF), which initially was presumed to be the consequence of extrarenal causes. Proteinuria and hematuria were only mild. In renal core biopsy, a membranoproliferative glomerulonephritis (MPGN) and prominent intracapillary hyaline monoclonal IgM thrombi were found in addition to acute tubular necrosis. Of note, the patient’s history was positive for purpuric skin changes, suspicious for cryoglobulinemia. However, serological tests for cryoglobulins were repeatedly negative. The ARF resolved before the start of immunomodulatory therapy for Waldenström’s macroglobulinemia.
The presence of MPGN with prominent hyaline thrombi in the context of Waldenström’s macroglobulinemia is uncommon and can be oligosymptomatic. We discuss this case in the context of previous literature and classifications suggested for monoclonal Ig-related renal pathologies.
KeywordsWaldenström’s macroglobulinemia MPGN Hyaline thrombi
Lymphoproliferative malignancies producing monoclonal immunoglobulins may cause different nephropathies. Compared to multiple myeloma, renal involvement in Waldenström’s macroglobulinemia (WM) is much more seldom and often manifests as IgM deposits along the glomerular basement membranes, amyloidosis or lymphomatous infiltration of the renal parenchyma, whereas cast nephropathy is almost never observed [1–4]. Morel-Maroger et al. described a renal manifestation of WM characterized by prominent intracapillary IgM thrombi and lack of relevant glomerular proliferation . This disease pattern has also been referred to as intracapillary monoclonal deposits disease (ICMDD) in the context of any IgM-secreting monoclonal proliferation . Prominent intracapillary hyaline thrombi can also develop in the context of cryoglobulinemia, containing a monoclonal immunoglobulin (Ig) often in the context of lymphoproliferative disorders (type I) or polyclonal with or without monoclonal Ig (type II and III, respectively), which may be associated with persistent infections and autoimmune syndromes [5, 6]. Although about 15% of WM cases are associated with type I cryoglobulins (CG), few patients have symptoms or complications . Cryoglobulinemic glomerulonephritis (CG-GN), often reported in type II cryoglobulinemia, is an exceedingly rare finding in WM .
At physical examination, the patient’s temperature was 38.2°C and her blood pressure was 110/70 mmHg. At the lung bases, the chest was dull to percussion with diminished breath sounds. The cardiac and abdominal examinations were normal. The extremities were remarkable for pitting ankle edema. The hands showed ulnar deviation and swan neck deformity. The skin revealed an unremarkable skin grafting wound on her right, and discrete palpable purpura on her left pretibial region. Renal ultrasound was normal. Although cardiac decompensation was suspected because of dyspnea, edema and pleural effusions and an elevation of BNP (2108 pg/ml), echocardiography showed only a slightly decreased cardiac ejection fraction (40-50%).
Laboratory data included a serum creatinine of 2.54 mg/dl and BUN of 96 mg/dl. Urine dipstick evaluation showed 2+ blood and no protein. The urinary sediment contained 292 erythrocytes/μl without dysmorphic forms. Additional laboratory tests performed during hospitalization included: high levels of rheumatoid factor (881 IU/ml) and anti-CCP antibodies (>340 U/ml), normal ANA serology, and negative hepatitis C serology. Urinary protein excretion was 1.23 g/24 h, Bence-Jones lambda was 226 mg/dl and Bence-Jones kappa 77.2 mg/dl. The serum protein electrophoresis showed a monoclonal IgM lambda band; serum IgM was 31.4 g/l. Despite repeated testing, CG serology remained negative.
A renal biopsy was performed.
In electron microscopy (EM) a prominent increase in mesangial matrix and mesangial and intracapillary hypercellularity with numerous inflammatory cells were seen (Figure 2G and H). The glomerular basement membranes focally showed mesangial cell interposition. Podocytes presented with foot-process effacement. The most striking finding was intracapillary deposits of electron-dense granular material, which, even at very high magnification, showed no fingerprint or tubuloreticular structures. Electron-dense deposits with identical structure were found subendothelially and intramembranously.
The lesion was classified as membranoproliferative glomerulonephritis (MPGN) with intracapillary IgM deposits in the context of WM accompanied by acute tubular necrosis. Because of the pattern of glomerulonephritis with an MPGN-like picture and prominent hyaline thrombi, an association with cryoglobulinemia was suggested.
In the further clinical course the ARF subsided without specific treatment and creatinine levels declined from 3.04 mg/dl to 1.3 mg/dl three weeks after admission. Nevertheless, we initiated an immunomodulatory therapy with rituximab, after which renal function continued to fluctuate. Repeated CG testing remained negative.
The reported case of MPGN with intracapillary thrombi is remarkable in several aspects.
First, because of heart failure signs and highly elevated BNP level, we suspected that ARF was due to cardiac decompensation as an extrarenal cause. The only slightly abnormal echocardiographic findings could be explained by the fact that at the time of the examination, cardiac function was already recovering from an acute event. The urine analysis showed only mild proteinuria and hematuria without dysmorphic erythrocytes, so that no distinct glomerular disease was expected. However, renal biopsy, in addition to the expected acute tubular necrosis, revealed a proliferative glomerulonephritis necessitating a specific immunomodulatory therapy. The renal function recovered before the start of the therapy, again arguing for a prerenal cause of acute renal failure. Thus, the finding of the glomerulonephritis was ‘incidental’ in the context of a renal biopsy performed for acute renal failure. Moreover, proliferative GN reported in the context of monoclonal lymphoproliferations is often associated with nephrotic syndrome [1, 8, 9], which was not true for our case, so that the MPGN pattern of injury was even less expected. Secondly, from the morphological point of view our case was reminiscent of CG-GN with monoclonal type I CG [10, 11], which would go very well in line with the glomerular proliferation and the purpuric skin manifestation. While a microtubular or fingerprint ultrastructure on EM is very specific for CG-GN, a finding of granular deposits as seen in our case does not prove or exclude this disorder [10, 12]. Nevertheless, CG-GN could not be proven because of repeatedly negative CG testing.
Another entity that might be considered in the differential diagnosis is WM-associated nephropathy with prominent intracapillary thrombi and, contrary to our case, lack of relevant proliferation or histiocytic infiltration [1, 3].
In monoclonal deposit nephropathies, CG presence very often is seen tied to the feature of cellular proliferation . However, several reports in literature can be found describing monoclonal intrarenal IgM deposits and marked glomerular proliferation sometimes with the typical picture of MPGN without proof of CG [1, 4, 8, 13–15]. Interestingly, negativity for CG is also present in a recently described proliferative glomerulonephritis with monoclonal IgG deposits (PGNMID) . Comparable to this entity associated with IgG, recently a case of proliferative GN with monoclonal IgM deposits, but without association with WM, was reported . This showed several similarities with the present case, including lack of evidence of CG, presence of a monoclonal IgM and prominent proliferation , so that this case and ours might both be classified as proliferative GN with monoclonal IgM deposits. In contrast to other reported cases that might belong to this group  our patient showed a lambda light chain restriction and was female, so that apparently this pattern of injury is not restricted to men and kappa light chain producing lymphoproliferation. The concomitantly observed minor peripheral capillary deposits of IgG, kappa light chains and C3c might either represent a trapping of immunoglobulins and complement in the widened basement membranes or be due to an immune activation maybe caused by the monoclonal IgM.
Presence of CG, conversely, is not always accompanied by prominent glomerular proliferation [3, 17]. Thus, glomerulopathies associated with monoclonal gammopathies include a spectrum of proliferative and non-proliferative GN which can, but need not be associated with the presence of CG. In addition, RA and its treatments can also lead to MPGN . Therefore it cannot be excluded that in the present case RA might be involved in the pathogenesis of MPGN.
Treatment for WM is usually indicated for conditions like progressive, severe anemia and hyperviscosity syndrome , for which there was no evidence in the present patient. Given the impressive renal changes linked to deposition of monoclonal antibodies, we nevertheless felt the urge to treat and suppress their production. The optimal treatment regimen for intrarenal monoclonal deposit disorders has yet to be defined. In general, treatment of the malignancy is expected to alleviate glomerulopathy . Because of the patient’s poor general condition, we opted for monotherapy with rituximab. This case illustrates the need for renal biopsy in ARF patients with a positive history for diseases that may be associated with more unusual forms of nephropathy.
Written informed consent was obtained from the patient’s husband for the publication of this Case report. A copy of the written consent is available for review by the Series Editor of this journal.
Acute renal failure
Intracapillary monoclonal deposits disease
Proliferative GN with monoclonal IgG deposits
We thank Monika Klewer for excellent technical assistance.
- Audard V, Georges B, Vanhille P, Toly C, Deroure B, Fakhouri F, Cuvelier R, Belenfant X, Surin B, Aucouturier P, et al: Renal lesions associated with IgM-secreting monoclonal proliferations: revisiting the disease spectrum. Clin J Am Soc Nephrol. 2008, 3 (5): 1339-1349. 10.2215/CJN.01600408.View ArticlePubMedPubMed CentralGoogle Scholar
- Dimopoulos MA, Alexanian R: Waldenstrom's macroglobulinemia. Blood. 1994, 83 (6): 1452-1459.PubMedGoogle Scholar
- Morel-Maroger L, Basch A, Danon F, Verroust P, Richet G: Pathology of the kidney in Waldenstrom's macroglobulinemia. study of sixteen cases. N Engl J Med. 1970, 283 (3): 123-129. 10.1056/NEJM197007162830304.View ArticlePubMedGoogle Scholar
- Veltman GA, van Veen S, Kluin-Nelemans JC, Bruijn JA, van Es LA: Renal disease in Waldenstrom's macroglobulinaemia. Nephrol Dial Transplant. 1997, 12 (6): 1256-1259. 10.1093/ndt/12.6.1256.View ArticlePubMedGoogle Scholar
- Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M: Biologic and clinical significance of cryoglobulins. a report of 86 cases. Am J Med. 1974, 57 (5): 775-788. 10.1016/0002-9343(74)90852-3.View ArticlePubMedGoogle Scholar
- Trejo O, Ramos-Casals M, Garcia-Carrasco M, Yague J, Jimenez S, de la Red G, Cervera R, Font J, Ingelmo M: Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore). 2001, 80 (4): 252-262. 10.1097/00005792-200107000-00004.View ArticleGoogle Scholar
- Kim YL, Gong SJ, Hwang YH, Joo JE, Cho YU, Lee JA, Sung SA, Lee SY, Kim NY: Waldenstrom macroglobulinemia with CD5+ expression presented as cryoglobulinemic glomerulonephropathy: a case report. J Korean Med Sci. 2011, 26 (6): 824-828. 10.3346/jkms.2011.26.6.824.View ArticlePubMedPubMed CentralGoogle Scholar
- Colovic N, Terzic T, Andelic B, Sretenovic M, Mihaljevic B, Lipkovski JM, Colovic M: Nephrotic syndrome and acute renal failure in non-Hodgkin lymphoplasmacytic lymphoma. Med Oncol. 2008, 25 (4): 458-461. 10.1007/s12032-008-9048-0.View ArticlePubMedGoogle Scholar
- Yahata M, Nakaya I, Takahashi S, Sakuma T, Sato H, Soma J: Proliferative glomerulonephritis with monoclonal IgM deposits without Waldenstrom's macroglobulinemia: case report and review of the literature. Clin Nephrol. 2012, 77 (3): 254-260.View ArticlePubMedGoogle Scholar
- Beddhu S, Bastacky S, Johnson JP: The clinical and morphologic spectrum of renal cryoglobulinemia. Medicine. 2002, 81 (5): 398-409. 10.1097/00005792-200209000-00005.View ArticlePubMedGoogle Scholar
- Feiner H, Gallo G: Ultrastructure in glomerulonephritis associated with cryoglobulinemia. a report of six cases and review of the literature. Am J Pathol. 1977, 88 (1): 145-162.PubMedPubMed CentralGoogle Scholar
- Herrera GA, Turbat-Herrera EA: Renal diseases with organized deposits: an algorithmic approach to classification and clinicopathologic diagnosis. Arch Pathol Lab Med. 2010, 134: 512-531.PubMedGoogle Scholar
- Moulin B, Ronco PM, Mougenot B, Francois A, Fillastre JP, Mignon F: Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas. Kidney Int. 1992, 42 (1): 127-135. 10.1038/ki.1992.270.View ArticlePubMedGoogle Scholar
- Ramos R, Poveda R, Sarra J, Domingo A, Carreras L, Grinyo JM: Renal involvement in non-malignant IgM gammopathy. Nephrol Dial Transplant. 2007, 22 (2): 627-630.View ArticlePubMedGoogle Scholar
- Stokes MB, Wood B, Alpers CE: Membranoproliferative glomerulonephritis associated with low-grade B cell lymphoma presenting in the kidney. Clin Nephrol. 2002, 57 (4): 303-309.View ArticlePubMedGoogle Scholar
- Nasr SH, Satoskar A, Markowitz GS, Valeri AM, Appel GB, Stokes MB, Nadasdy T, D'Agati VD: Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol. 2009, 20 (9): 2055-2064. 10.1681/ASN.2009010110.View ArticlePubMedPubMed CentralGoogle Scholar
- Pais B, Panades MJ, Ramos J, Montoliu J: Glomerular involvement in type I monoclonal cryoglobulinaemia. Nephrol Dial Transplant. 1995, 10 (1): 130-132.PubMedGoogle Scholar
- Ting HC, Wang F: Mesangiocapillary (membranoproliferative) glomerulonephritis and rheumatoid arthritis. Br Med J. 1977, 1 (6056): 270-271.View ArticlePubMedPubMed CentralGoogle Scholar
- Johnson SA, Birchall J, Luckie C, Oscier DG, Owen RG: Guidelines on the management of Waldenstrom macroglobulinaemia. Br J Haematol. 2006, 132 (6): 683-697. 10.1111/j.1365-2141.2005.05948.x.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2369/13/172/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.